The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of minimal residual disease in bone marrow by NGF and in peripheral blood by mass spectrometry in newly diagnosed multiple myeloma patients enrolled in the GEM2012MENOS65 clinical trial.
 
Noemi Puig
Honoraria - Amgen; Celgene/Bristol-Myers Squibb; Janssen; Takeda; The Binding Site
Consulting or Advisory Role - Amgen; Celgene/Bristol-Myers Squibb; Janssen-Cilag; Takeda
Speakers' Bureau - Celgene/Bristol-Myers Squibb
Research Funding - Amgen; Celgene/Bristol-Myers Squibb; Janssen-Cilag; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene/Bristol-Myers Squibb; Janssen-Cilag; Takeda
 
Bruno Paiva
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Celgene; Janssen-Cilag; Sanofi; Takeda
Speakers' Bureau - Celgene
Research Funding - Celgene; Janssen-Cilag; Sanofi; Takeda
 
Teresa Contreras
No Relationships to Disclose
 
M. Teresa Cedena
Honoraria - Abbvie; Celgene/Bristol-Myers Squibb; Janssen
 
Laura Rosiñol
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Sanofi
 
Joaquín Martínez
Speakers' Bureau - Celgene/Bristol-Myers Squibb; Incyte; Janssen-Cilag; Novartis
Research Funding - Bristol-Myers Squibb
 
Albert Oriol
Consulting or Advisory Role - Amgen; Celgene; Janssen
Speakers' Bureau - Amgen; Celgene
 
Maria Jesus Blanchard
Consulting or Advisory Role - Amgen; Janssen-Cilag
Speakers' Bureau - Celgene
 
Rafael Rios
Consulting or Advisory Role - Celgene; Janssen
 
María Belén Iñigo
No Relationships to Disclose
 
Anna Sureda Balari
Honoraria - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Novartis; Takeda
Speakers' Bureau - Takeda
Other Relationship - Celgene; Gilead Sciences; Roche; Sanofi; Takeda
 
Hernández-Garcia Miguel Teodoro
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen; Novartis; Roche
Research Funding - Celgene
 
Javier de La Rubia
Speakers' Bureau - Amgen; Bristol-Myers Squibb
Expert Testimony - Amgen; Celgene; Janssen
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Janssen; Sanofi
 
Isabel Krsnik
Honoraria - Amgen; Celgene; Janssen; Takeda
Consulting or Advisory Role - Celgene
Research Funding - Janssen; Prothena
 
Moraleda José María
Consulting or Advisory Role - Celgene; Gilead Sciences
Research Funding - Pfizer
 
Alberto Orfao
Consulting or Advisory Role - Cytognos
Speakers' Bureau - Abbvie; Alexion Pharmaceuticals; BD Biosciences; Novartis; Pfizer
 
Joan Blade
Honoraria - Amgen; Celgene; Janssen; Oncopeptides; Takeda
 
Jesús F. San-Miguel
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
 
Juan José Lahuerta
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag
Travel, Accommodations, Expenses - Celgene
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda